Volume 18 Supplement 1
Publication costs for this supplement were funded by the 11th European Headache Federation Congress and the 31st National Congress of the Italian Society for the Study of Headaches. PM is on the advisory boards for Allergan, Amgen, Teva, Novartis, ElectroCore, and speaker bureau for Allergan, Bayer, Sanofi. PM has received reimbursement from European Medicines Agency, Springer Nature and funding from Elytra Pharma. PM is an employee of Springer Nature. DDM has received honoraria from lecturing, research or clinical trial grants and consulting fees from Allergan, Amgen, Biogen, Brain Therapeutics, Eli Lily, Gammacore, Genesis Pharma, Novartis, Sanofi-Genzyme and Teva. FP declares no competing interest.
Rome, Italy01-03 December 2017
Edited by Paolo Martelletti, Dimos-Dimitrios Mitsikostas and Francesco Pierelli
The Journal of Headache and Pain is the official journal of the European Headache Federation and Lifting the Burden.
2022 Citation Impact
7.4 - 2-year Impact Factor
7.1 - 5-year Impact Factor
2.002 - SNIP (Source Normalized Impact per Paper)
1.593 - SJR (SCImago Journal Rank)
2022 Speed
2 days submission to first editorial decision for all manuscripts (Median)
49 days submission to accept (Median)
2022 Usage
4,377,089 downloads
9,457 Altmetric mentions